{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:12:08Z","timestamp":1790993528941,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPGBJ0023"],"award-info":[{"award-number":["CMRPGBJ0023"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 110-2314-B-182A-155-MY3"],"award-info":[{"award-number":["MOST 110-2314-B-182A-155-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The course of vitiligo is unpredictable, with periods of disease flare-ups and prolonged recovery periods. It is essential to establish a biomarker profile as a substitute marker for disease activity to predict disease activity, severity, and prognosis prediction. The use of localized skin interstitial fluid as biomarkers has recently gained interest, but extensive studies of the association between skin interstitial fluid, plasma, and the disease course is lacking. This study aims to evaluate the cytokine expression profiles in the skin and plasma and the utility of the biomarker panel in assessing disease activity, severity, and prognosis in patients with vitiligo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective cohort study, 86 patients and 34 healthy controls were recruited from the outpatient department of a tertiary medical center from March 2019 to September 2021. All patients were of Asian ethnicity. Two independent investigators evaluated disease activity and severity with longitudinal follow-ups for treatment response for a-12 month period. Ultrasensitive multiplex cytokine panel and single-molecule counting technology immunoassays were used to study the cytokine expression in skin interstitial fluid and plasma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>IFN-\u03b3 and its\u2019 signature cytokines, including CXCL9, CXCL10, and GzmB, are most highly expressed in the vitiligo patients\u2019 lesion skin interstitial fluid and plasma compared to healthy control. By way of comparison, no significant changes in IL-1\u03b2, IL-13, IL-15, IL-17A, IL-18 were observed. Receiver operating characteristic analysis revealed that IFN-\u03b3 is the most sensitive and specific marker in predicting disease activity, followed by CXCL10 and GzmB. CXCL-9 was sensitive and specific in diagnosing vitiligo disease severity. The decrease in IFN-\u03b3 expression level is positively correlated with the treatment response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IFN-\u03b3, CXCL9, CXCL10, and GzmB are highly expressed in vitiligo patients\u2019 lesion skin and plasma and may serve as biomarkers for the clinical activity, severity, and prognosis prediction in vitiligo patients. Among all, IFN-\u03b3 exerts the highest predictive value in disease activity and treatment response, supporting the critical role of IFN-\u03b3 in the pathogenesis of vitiligo.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2022.872458","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T01:22:43Z","timestamp":1649294563000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Skin Interstitial Fluid and Plasma Multiplex Cytokine Analysis Reveals IFN-\u03b3 Signatures and Granzyme B as Useful Biomarker for Activity, Severity and Prognosis Assessment in Vitiligo"],"prefix":"10.3389","volume":"13","author":[{"given":"Chau Yee","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Chuan","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Pei","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jr","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Han","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lung","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Trans Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/s41467-019-09963-8","article-title":"Innate Lymphocyte-Induced CXCR3B-Mediated Melanocyte Apoptosis Is a Potential Initiator of T-Cell Autoreactivity in Vitiligo","volume":"10","author":"Tulic","year":"2019","journal-title":"Nat Commun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01408.x","article-title":"Specific Cytotoxic T Lymphocyte Responses Against Melan-A\/MART1, Tyrosinase and Gp100 in Vitiligo by the Use of Major Histocompatibility Complex\/Peptide Tetramers: The Role of Cellular Immunity in the Etiopathogenesis of Vitiligo","volume":"117","author":"Palermo","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.01363.x","article-title":"HLA-A2 Restricted, Melanocyte-Specific CD8+ T Lymphocytes Detected in Vitiligo Patients are\u00a0Related to Disease Activity and Are Predominantly Directed Against MelanA\/Mart1","volume":"116","author":"Lang","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900027","article-title":"The Role of Memory CD8(+) T Cells in Vitiligo","volume":"203","author":"Riding","year":"2019","journal-title":"J Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","article-title":"Suction Blistering the Lesional Skin of Vitiligo Patients Reveals Useful Biomarkers of Disease Activity","volume":"76","author":"Strassner","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.12.028","article-title":"Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression","volume":"137","author":"Rezk","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-97296-2","article-title":"CXCL9 as a Key Biomarker of Vitiligo Activity and Prediction of the Success of Cultured Melanocyte Transplantation","volume":"11","author":"Lin","year":"2021","journal-title":"Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-021-02228-9","article-title":"Systemic CXCL10 Is a Predictive Biomarker of Vitiligo Lesional Skin Infiltration, PUVA, NB-UVB and Corticosteroid Treatment Response and Outcome","volume":"314","author":"El-Domyati","year":"2021","journal-title":"Arch Dermatol Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12667","article-title":"CXCL-10 and Interleukin-6 Are Reliable Serum Markers for Vitiligo Activity: A Multicenter Cross-Sectional Study","volume":"31","author":"Abdallah","year":"2018","journal-title":"Pigment Cell Melanoma Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.autrev.2016.01.004","article-title":"The Role of IL-17 in Vitiligo: A Review","volume":"15","author":"Singh","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.03.020","article-title":"CXCL12 as a Predictor of Vitiligo Activity and Disease Progression","volume":"137","author":"Alexeev","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.02.012","article-title":"Alterations of CXCL12 in Serum of Patients With Vitiligo","volume":"137","author":"Speeckaert","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13908","article-title":"Elevated Serum Level of Interleukin-15 in Vitiligo Patients and its Correlation With Disease Severity But Not Activity","volume":"20","author":"Atwa","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.07.005","article-title":"Biomarkers of Disease Activity in Vitiligo: A Systematic Review","volume":"16","author":"Speeckaert","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jamadermatol.2019.4483","article-title":"Association of Clinical Markers With Disease Progression in Patients With Vitiligo From China","volume":"156","author":"Zhang","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18950","article-title":"Reliability and Validity of the Vitiligo Signs of Activity Score (VSAS)","volume":"183","author":"Van Geel","year":"2020","journal-title":"Br J Dermatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.4.407","article-title":"Association of the K\u00f6bner Phenomenon With Disease Activity and Therapeutic Responsiveness in Vitiligo Vulgaris","volume":"135","author":"Njoo","year":"1999","journal-title":"Arch Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.070","article-title":"The Vitiligo Extent Score (VES) and the VESplus are Responsive Instruments to Assess Global and Regional Treatment Response in Patients With Vitiligo","volume":"79","author":"Van Geel","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.613031","article-title":"Vitiligo Skin Biomarkers Associated With Favorable Therapeutic Response","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1021\/pr800545q","article-title":"Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group","volume":"8","author":"Tuck","year":"2009","journal-title":"J Proteome Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.597632","article-title":"Inflammatory Markers in Suction Blister Fluid: A Comparative Study Between Interstitial Fluid and Plasma","volume":"11","author":"Sj\u00f6bom","year":"2020","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2011.06.033","article-title":"Multiplex Measurement of Proinflammatory Cytokines in Human Serum: Comparison of the Meso Scale Discovery Electrochemiluminescence Assay and the Cytometric Bead Array","volume":"372","author":"Dabitao","year":"2011","journal-title":"J Immunol Methods"},{"key":"B24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ymeth.2018.10.018","article-title":"Quantitation of Low Abundant Soluble Biomarkers Using High Sensitivity Single Molecule Counting Technology","volume":"158","author":"Hwang","year":"2019","journal-title":"Methods"},{"key":"B25","volume-title":"Sample Size Tables for Clinical Studies","author":"Machin","year":"1997"},{"key":"B26","volume-title":"Biostatistical Analysis. 2nd Edition","author":"Zar","year":"1984"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2011.00838.x","article-title":"Koebner\u2019s Phenomenon in Vitiligo: European Position Paper","volume":"24","author":"Van Geel","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.09.004","article-title":"Efficacy, Predictors of Response, and Long-Term Follow-Up in Patients With Vitiligo Treated With Narrowband UVB Phototherapy","volume":"56","author":"Nicolaidou","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance Therapy of Adult Vitiligo With 0.1% Tacrolimus Ointment: A Randomized, Double Blind, Placebo\u2013Controlled Study","volume":"135","author":"Cavali\u00e9","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.200600938","article-title":"Suction Blister Fluid as Potential Body Fluid for Biomarker Proteins","volume":"7","author":"Kool","year":"2007","journal-title":"PROTEOMICS"},{"key":"B31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1067\/mjd.2002.120473","article-title":"Increased Interleukin 10, Tumor Necrosis Factor Alpha, and Interleukin 6 Levels in Blister Fluid of Toxic Epidermal Necrolysis","volume":"47","author":"Correia","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.03.009","article-title":"Serum and Blister Fluid Levels of Cytokines and Chemokines in Pemphigus and Bullous Pemphigoid","volume":"18","author":"Kowalski","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.463","article-title":"A Mouse Model of Vitiligo With Focused Epidermal Depigmentation Requires IFN-\u03b3 for Autoreactive CD8+ T-Cell Accumulation in the Skin","volume":"132","author":"Harris","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1304988111","article-title":"IFN-Gamma Signaling Maintains Skin Pigmentation Homeostasis Through Regulation of Melanosome Maturation","volume":"111","author":"Natarajan","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2080","article-title":"Interferon-Gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo","volume":"95","author":"Yang","year":"2015","journal-title":"Acta Dermato Venereol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.07.011","article-title":"Vitiligo: Mechanistic Insights Lead to Novel Treatments","volume":"140","author":"Frisoli","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2012.0171","article-title":"Involvement of Interferon-Gamma Genetic Variants and Intercellular Adhesion Molecule-1 in Onset and Progression of Generalized Vitiligo","volume":"33","author":"Dwivedi","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1641","article-title":"Single-Molecule Enzyme-Linked Immunosorbent Assay Detects Serum Proteins at Subfemtomolar Concentrations","volume":"28","author":"Rissin","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jdermsci.2021.10.006","article-title":"Pathological Functions of Granzyme B in Inflammatory Skin Diseases","volume":"104","author":"Hiroyasu","year":"2021","journal-title":"J Dermatol Sci"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20604-3","article-title":"Granzyme B Inhibition Reduces Disease Severity in Autoimmune Blistering Diseases","volume":"12","author":"Hiroyasu","year":"2021","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-31233-8","article-title":"Genetic Polymorphisms of GZMB and Vitiligo: A Genetic Association Study Based on Chinese Han Population","volume":"8","author":"Xu","year":"2018","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-79705-0","article-title":"Association of GZMB Polymorphisms and Susceptibility to Non-Segmental Vitiligo in a Korean Population","volume":"11","author":"Jeong","year":"2021","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3780138","article-title":"Local Immune Response in Skin of Generalized Vitiligo Patients","volume":"80","author":"Van Den Wijngaard","year":"2000","journal-title":"Lab Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jid.2020.06.013","article-title":"The Possible Linkage of Granzyme B-Producing Skin T Cells With the Disease Prognosis of Alopecia Areata","volume":"141","author":"Koguchi-Yoshioka","year":"2021","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.872458\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T01:22:47Z","timestamp":1649294567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.872458\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2022.872458"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.872458","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,7]]},"article-number":"872458"}}